{"id":"https://openalex.org/W3155582003","doi":"https://doi.org/10.1182/bloodadvances.2020003431","title":"Deciphering the mechanisms of CC-122 resistance in DLBCL via a genome-wide CRISPR screen","display_name":"Deciphering the mechanisms of CC-122 resistance in DLBCL via a genome-wide CRISPR screen","alternate_titles":[],"publication_year":2021,"publication_date":"2021-04-13","ids":{"openalex":"https://openalex.org/W3155582003","doi":"https://doi.org/10.1182/bloodadvances.2020003431","mag":"3155582003","pmid":"https://pubmed.ncbi.nlm.nih.gov/33847741","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8045513"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2020003431","doi":"https://doi.org/10.1182/bloodadvances.2020003431","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2020003431","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3155582003"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1182/bloodadvances.2020003431","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089618283","display_name":"Zhongying Mo","orcid":"https://orcid.org/0009-0006-3459-1365","observed_orcids":["https://orcid.org/0009-0006-3459-1365"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Zhongying Mo","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Scott Wood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Wood","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006735334","display_name":"Shawn Namiranian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shawn Namiranian","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064205083","display_name":"Reina Mizukoshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Reina Mizukoshi","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020111471","display_name":"Stephanie Weng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Weng","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036283039","display_name":"In Sock Jang","orcid":"https://orcid.org/0000-0002-7285-7885","observed_orcids":["https://orcid.org/0000-0002-7285-7885"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"In Sock Jang","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":"https://orcid.org/0000-0002-7285-7885","affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069870180","display_name":"Celia Fontanillo","orcid":"https://orcid.org/0000-0002-3631-7881","observed_orcids":["https://orcid.org/0000-0002-3631-7881"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Celia Fontanillo","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088182912","display_name":"Joshua M. Baughman","orcid":"https://orcid.org/0000-0002-3975-1528","observed_orcids":["https://orcid.org/0000-0002-3975-1528"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua M. Baughman","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":"https://orcid.org/0000-0002-3975-1528","affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013841899","display_name":"Arianna Silva-Torres","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arianna Silva-Torres","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027163895","display_name":"Michelle Slade","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Slade","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003483753","display_name":"Marwa Khater","orcid":"https://orcid.org/0009-0002-5482-8711","observed_orcids":["https://orcid.org/0009-0002-5482-8711"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marwa Khater","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100774874","display_name":"Kai Wang","orcid":"https://orcid.org/0000-0003-0567-3004","observed_orcids":["https://orcid.org/0000-0003-0567-3004"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kai Wang","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":"https://orcid.org/0000-0003-0567-3004","affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059110616","display_name":"Mark Rolfe","orcid":"https://orcid.org/0009-0001-7585-2684","observed_orcids":["https://orcid.org/0009-0001-7585-2684"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Rolfe","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101791178","display_name":"Gang Lu","orcid":"https://orcid.org/0000-0002-2138-1522","observed_orcids":["https://orcid.org/0000-0002-2138-1522"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gang Lu","raw_affiliation_strings":["Bristol Myers Squibb, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol Myers Squibb, San Diego, CA","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089618283"],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":{"value":3800,"currency":"USD","value_usd":3800},"fwci":1.0448,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.73437421,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"5","issue":"7","first_page":"2027","last_page":"2039"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.048900000751018524,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cereblon-e3-ligase-modulator","display_name":"cereblon E3 ligase modulator","score":0.8519999980926514},{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7689999938011169},{"id":"https://openalex.org/keywords/crispr-cas9-screening","display_name":"CRISPR-Cas9 screen","score":0.8669999837875366},{"id":"https://openalex.org/keywords/cyld","display_name":"CYLD","score":0.6639999747276306},{"id":"https://openalex.org/keywords/nfkbia","display_name":"NFKBIA","score":0.9380000233650208},{"id":"https://openalex.org/keywords/traf2","display_name":"TRAF2","score":0.9890000224113464},{"id":"https://openalex.org/keywords/traf3","display_name":"TRAF3","score":1.0},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.8560000061988831},{"id":"https://openalex.org/keywords/kctd5","display_name":"KCTD5","score":0.9430000185966492},{"id":"https://openalex.org/keywords/ambra1","display_name":"AMBRA1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.8169999718666077},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.47099998593330383}],"concepts":[{"id":"https://openalex.org/C134459356","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin ligase","level":4,"score":0.7289797067642212},{"id":"https://openalex.org/C2778540781","wikidata":"https://www.wikidata.org/wiki/Q21112029","display_name":"Cereblon","level":5,"score":0.6239035725593567},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5757445693016052},{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.5691682696342468},{"id":"https://openalex.org/C123233396","wikidata":"https://www.wikidata.org/wiki/Q14914361","display_name":"TRAF2","level":4,"score":0.5360795259475708},{"id":"https://openalex.org/C175114707","wikidata":"https://www.wikidata.org/wiki/Q408483","display_name":"DNA ligase","level":3,"score":0.5287734270095825},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.5097529292106628},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5092081427574158},{"id":"https://openalex.org/C183786373","wikidata":"https://www.wikidata.org/wiki/Q5964993","display_name":"Signal transducing adaptor protein","level":3,"score":0.48189932107925415},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47462451457977295},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.43647778034210205},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4067588746547699},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.37270450592041016},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3442145586013794},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3248831033706665},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.29760250449180603},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2774509787559509},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.2565304934978485},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.22910341620445251},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13633966445922852},{"id":"https://openalex.org/C93880895","wikidata":"https://www.wikidata.org/wiki/Q2579343","display_name":"Tumor necrosis factor receptor","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010881","descriptor_name":"Piperidones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015221","descriptor_name":"Potassium Channels","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D044767","descriptor_name":"Ubiquitin-Protein Ligases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048868","descriptor_name":"Adaptor Proteins, Signal Transducing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052999","descriptor_name":"Quinazolinones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064112","descriptor_name":"Clustered Regularly Interspaced Short Palindromic Repeats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/bloodadvances.2020003431","doi":"https://doi.org/10.1182/bloodadvances.2020003431","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2020003431","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmid:33847741","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33847741","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8045513","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8045513/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2020003431","doi":"https://doi.org/10.1182/bloodadvances.2020003431","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2020003431","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1527383154","https://openalex.org/W1595081780","https://openalex.org/W1628369270","https://openalex.org/W1644306425","https://openalex.org/W1825540737","https://openalex.org/W1969998568","https://openalex.org/W1981988641","https://openalex.org/W1997952190","https://openalex.org/W2009874228","https://openalex.org/W2015345028","https://openalex.org/W2029454644","https://openalex.org/W2035135710","https://openalex.org/W2039186983","https://openalex.org/W2042872424","https://openalex.org/W2056663185","https://openalex.org/W2066713758","https://openalex.org/W2068412287","https://openalex.org/W2072646319","https://openalex.org/W2079069420","https://openalex.org/W2105415988","https://openalex.org/W2118028844","https://openalex.org/W2121652706","https://openalex.org/W2150587745","https://openalex.org/W2470671857","https://openalex.org/W2618306819","https://openalex.org/W2618969857","https://openalex.org/W2797584152","https://openalex.org/W2883654450","https://openalex.org/W2884204281","https://openalex.org/W2885735594","https://openalex.org/W2891958511","https://openalex.org/W2921072067","https://openalex.org/W2933195911","https://openalex.org/W2960291242","https://openalex.org/W3001407138","https://openalex.org/W3002249367","https://openalex.org/W3046325703"],"related_works":["https://openalex.org/W1628369270","https://openalex.org/W4378469663","https://openalex.org/W4378952773","https://openalex.org/W4376641512","https://openalex.org/W4400241152","https://openalex.org/W3207056536","https://openalex.org/W4229002347","https://openalex.org/W7130314056","https://openalex.org/W4310166292","https://openalex.org/W2960291242"],"abstract_inverted_index":{"CC-122":[0,27,50,75,163,177,199],"is":[1],"a":[2,45,52],"next-generation":[3],"cereblon":[4,111],"E3":[5,88],"ligase-modulating":[6],"agent":[7],"that":[8,101,212],"has":[9],"demonstrated":[10],"promising":[11],"clinical":[12,217,234],"efficacy":[13],"in":[14,41,51,61,134,162,165,178,190,201,206,219],"patients":[15,220,237],"with":[16,57,216,238],"relapsed":[17],"or":[18,83,118],"refractory":[19],"diffuse":[20],"large":[21],"B-cell":[22],"lymphoma":[23],"(R/R":[24],"DLBCL).":[25],"Mechanistically,":[26],"induces":[28,120],"the":[29,70,86,108,123,144,148,154,223],"degradation":[30],"of":[31,85,96,114,122,136,142,147,156,172,184,198,225,236],"IKZF1/3,":[32],"leading":[33],"to":[34,66,72,106,110,176,187],"T-cell":[35],"activation":[36],"and":[37,98,129,168,180,194,221],"robust":[38],"cell-autonomous":[39],"killing":[40],"DLBCL.":[42,240],"We":[43],"report":[44],"genome-wide":[46],"CRISPR/Cas9":[47],"screening":[48],"for":[49,228],"DLBCL":[53,63,138,202],"cell":[54,64,139,195,203],"line":[55],"SU-DHL-4":[56,179],"follow-up":[58],"mechanistic":[59],"characterization":[60],"6":[62,137],"lines":[65,204],"identify":[67],"genes":[68,77],"regulating":[69],"response":[71,109],"CC-122.":[73],"Top-ranked":[74],"resistance":[76,164,175,188,200,218],"encode,":[78],"not":[79,103],"only":[80],"well-defined":[81],"members":[82],"regulators":[84],"CUL4/DDB1/RBX1/CRBN":[87],"ubiquitin":[89,150],"ligase":[90,151],"complex,":[91,152],"but":[92],"also":[93],"key":[94],"components":[95],"signaling":[97],"transcriptional":[99],"networks":[100],"have":[102],"been":[104],"shown":[105],"modulate":[107],"modulators.":[112],"Ablation":[113],"CYLD,":[115],"NFKBIA,":[116],"TRAF2,":[117],"TRAF3":[119],"hyperactivation":[121],"canonical":[124],"and/or":[125],"noncanonical":[126],"NF-\u03baB":[127],"pathways":[128],"subsequently":[130],"diminishes":[131],"CC-122-induced":[132],"apoptosis":[133],"5":[135],"lines.":[140],"Depletion":[141],"KCTD5,":[143],"substrate":[145],"adaptor":[146],"CUL3/RBX1/KCTD5":[149],"promotes":[153],"stabilization":[155],"its":[157],"cognate":[158],"substrate,":[159],"GNG5,":[160],"resulting":[161],"HT,":[166],"SU-DHL-4,":[167],"WSU-DLCL2.":[169],"Furthermore,":[170],"knockout":[171,183],"AMBRA1":[173],"renders":[174],"U-2932,":[181],"whereas":[182],"RFX7":[185],"leads":[186],"specifically":[189],"SU-DHL-4.":[191],"The":[192],"ubiquitous":[193],"line-specific":[196],"mechanisms":[197],"revealed":[205],"this":[207],"work":[208],"pinpoint":[209],"genetic":[210],"alternations":[211],"are":[213],"potentially":[214],"associated":[215],"facilitate":[222],"development":[224],"biomarker":[226],"strategies":[227],"patient":[229],"stratification,":[230],"which":[231],"may":[232],"improve":[233],"outcomes":[235],"R/R":[239]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3155582003","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2021-04-26T00:00:00"}
